Literature DB >> 23971640

Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).

Melissa A Cadnapaphornchai1.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disease, affecting 1 in 1000 individuals. Previously termed "adult polycystic kidney disease", ADPKD is now known to have important clinical manifestations beginning early in life and even in utero. Hypertension is an important risk factor for progressive renal and cardiovascular disease in children with ADPKD and may signify irremediable organ injury. The purpose of this article is to review current knowledge and treatment strategies in hypertension associated with pediatric ADPKD.

Entities:  

Mesh:

Year:  2013        PMID: 23971640     DOI: 10.2174/1573402111309010004

Source DB:  PubMed          Journal:  Curr Hypertens Rev        ISSN: 1573-4021


  4 in total

Review 1.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

2.  Feeding soy protein isolate and oils rich in omega-3 polyunsaturated fatty acids affected mineral balance, but not bone in a rat model of autosomal recessive polycystic kidney disease.

Authors:  Kaitlin H Maditz; Brenda J Smith; Matthew Miller; Chris Oldaker; Janet C Tou
Journal:  BMC Nephrol       Date:  2015-02-10       Impact factor: 2.388

3.  Central blood pressure and measures of early vascular disease in children with ADPKD.

Authors:  Matko Marlais; Sreedevi Rajalingam; Haotian Gu; Alexandra Savis; Manish D Sinha; Paul Jd Winyard
Journal:  Pediatr Nephrol       Date:  2019-06-26       Impact factor: 3.714

4.  Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease.

Authors:  William E Sweeney; Philip Frost; Ellis D Avner
Journal:  World J Nephrol       Date:  2017-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.